Evidence map›Paper›PMID 31805010›Full record

ArticleJCI insight2020

Lupus-associated endogenous retroviral LTR polymorphism and epigenetic imprinting promote HRES-1/RAB4 expression and mTOR activation.

Aparna Godavarthy, Ryan Kelly, John Jimah, Miguel Beckford, Tiffany Caza, David Fernandez, Nick Huang, Manuel Duarte, Joshua Lewis, Hind J Fadel and 3 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. RAB4A DRIVES PROINFLAMMATORY CD4Research square · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Aparna GodavarthyDivision of Rheumatology, Department of Medicine.
Ryan KellyDivision of Rheumatology, Department of Medicine.
John JimahDivision of Rheumatology, Department of Medicine.
Miguel BeckfordDivision of Rheumatology, Department of Medicine.
Tiffany CazaDivision of Rheumatology, Department of Medicine.
David FernandezDivision of Rheumatology, Department of Medicine.
Nick HuangDivision of Rheumatology, Department of Medicine.
Manuel DuarteDivision of Rheumatology, Department of Medicine.
Joshua LewisDivision of Rheumatology, Department of Medicine.
Hind J FadelDepartment of Molecular Medicine, Mayo Clinic College of Medicine, Rochester, New York, USA.
Eric M PoeschlaDepartment of Molecular Medicine, Mayo Clinic College of Medicine, Rochester, New York, USA.
Katalin BankiDepartment of Pathology, State University of New York, Upstate Medical University, College of Medicine, Syracuse, New York, USA.
Andras PerlDivision of Rheumatology, Department of Medicine.
Center for Rheumatology · USSUNY Upstate Medical University · USMayo Clinic · US

Funding

SLE Treatment with N-acetylcysteineU01AR076092 · NIAMS · UPSTATE MEDICAL UNIVERSITY · PI Michael P McDermott, Andras Perl · 2020 to 2026
$7.9M
Metabolic Control of T-cell Lineage Specification in SLER01AI072648 · NIAID · UPSTATE MEDICAL UNIVERSITY · PI PERL, ANDRAS · 2008 to 2024
$6.1M
IMPACT OF HRES-1 ENDOGENOUS RETROVIRUS IN SLER01AI048079 · NIAID · UPSTATE MEDICAL UNIVERSITY · PI PERL, ANDRAS · 2000 to 2013
$2.7M
Endocytic Control of Autophagosome Formation in Lupus T cellsR01AI122176 · NIAID · UPSTATE MEDICAL UNIVERSITY · PI PERL, ANDRAS · 2016 to 2020
$2.0M
Genetic and Immunological Impact of the HRES-1/Rab4 Locus in SLER56AI048079 · NIAID · UPSTATE MEDICAL UNIVERSITY · PI PERL, ANDRAS · 2008 to 2008
$275k
NIAID NIH HHS R01 AI048079NIAID NIH HHS R01 AI072648NIAID NIH HHS R01 AI122176NIAID NIH HHS R56 AI048079NIAMS NIH HHS U01 AR076092
6 · The paper itself

Abstract

Overexpression and long terminal repeat (LTR) polymorphism of the HRES‑1/Rab4 human endogenous retrovirus locus have been associated with T cell activation and disease manifestations in systemic lupus erythematosus (SLE). Although genomic DNA methylation is diminished overall in SLE, its role in HRES-1/Rab4 expression is unknown. Therefore, we determined how lupus-associated polymorphic rs451401 alleles of the LTR regulate transcription from the HRES-1/Rab4 promoter and thus affect T cell activation. The results showed that cytosine-119 is hypermethylated while cytosine-51 of the promoter and the LTR enhancer are hypomethylated in SLE. Pharmacologic or genetic inactivation of DNA methyltransferase 1 augmented the expression of HRES-1/Rab4. The minimal promoter was selectively recognized by metabolic stress sensor NRF1 when cytosine-119 but not cytosine-51 was methylated, and NRF1 stimulated HRES-1/Rab4 expression in human T cells. In turn, IRF2 and PSIP1 bound to the LTR enhancer and exerted control over HRES-1/Rab4 expression in rs451401 genotype- and methylation-dependent manners. The LTR enhancer conferred markedly greater expression of HRES-1/Rab4 in subjects with rs451401CC over rs451401GG alleles that in turn promoted mechanistic target of rapamycin (mTOR) activation upon T cell receptor stimulation. HRES-1/Rab4 alone robustly activated mTOR in human T cells. These findings identify HRES-1/Rab4 as a methylation- and rs451401 allele-dependent transducer of environmental stress and controller of T cell activation.

Indexed as

Epigenesis, GeneticAdaptor Proteins, Signal TransducingAdolescentAdultAgedAllelesDNA (Cytosine-5-)-Methyltransferase 1DNA MethylationEndogenous RetrovirusesFemaleHCT116 CellsHeLa CellsHumansLupus Erythematosus, SystemicMiddle AgedNuclear Respiratory Factor 1Adaptor Proteins, Signal TransducingDNA (Cytosine-5-)-Methyltransferase 1DNMT1 protein, humanMTOR protein, humanNRF1 protein, humanNuclear Respiratory Factor 1PSIP1 protein, humanReceptors, Antigen, T-CellTOR Serine-Threonine KinasesTranscription FactorsImmunologyLupusRheumatologyT cells

Identifiers

PMID31805010
PMCPMC7030820
OpenAlexW2992897418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.